Literature DB >> 16926413

Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model.

Derek J Fisher1, Mariano E Fernandez-Miyakawa, Sameera Sayeed, Rachael Poon, Victoria Adams, Julian I Rood, Francisco A Uzal, Bruce A McClane.   

Abstract

The gram-positive anaerobe Clostridium perfringens produces a large arsenal of toxins that are responsible for histotoxic and enteric infections, including enterotoxemias, in humans and domestic animals. C. perfringens type C isolates, which cause rapidly fatal diseases in domestic animals and enteritis necroticans in humans, contain the genes for alpha toxin (plc), perfringolysin O (pfoA), beta toxin (cpb), and sometimes beta2 toxin (cpb2) and/or enterotoxin (cpe). Due to the economic impact of type C-induced diseases, domestic animals are commonly vaccinated with crude type C toxoid (prepared from inactivated culture supernatants) or bacterin/toxoid vaccines, and it is not clear which toxin(s) present in these vaccines actually elicits the protective immune response. To improve type C vaccines, it would be helpful to assess the contribution of each toxin present in type C supernatants to lethality. To address this issue, we surveyed a large collection of type C isolates to determine their toxin-producing abilities. When late-log-phase vegetative culture supernatants were analyzed by quantitative Western blotting or activity assays, most type C isolates produced at least three lethal toxins, alpha toxin, beta toxin, and perfringolysin O, and several isolates also produced beta2 toxin. In the mouse intravenous injection model, beta toxin was identified as the main lethal factor present in type C late-log-phase culture supernatants. This conclusion was based on monoclonal antibody neutralization studies and regression analyses in which the levels of alpha toxin, beta toxin, perfringolysin O, and beta2 toxin production were compared with lethality. Collectively, our results highlight the importance of beta toxin for type C-induced toxemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926413      PMCID: PMC1594841          DOI: 10.1128/IAI.00534-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens.

Authors:  W Ba-Thein; M Lyristis; K Ohtani; I T Nisbet; H Hayashi; J I Rood; T Shimizu
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

2.  Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins.

Authors:  Tohru Shimizu; Harumi Yaguchi; Kaori Ohtani; Sayera Banu; Hideo Hayashi
Journal:  Mol Microbiol       Date:  2002-01       Impact factor: 3.501

3.  Development of a duplex PCR genotyping assay for distinguishing Clostridium perfringens type A isolates carrying chromosomal enterotoxin (cpe) genes from those carrying plasmid-borne enterotoxin (cpe) genes.

Authors:  Qiyi Wen; Kazuaki Miyamoto; Bruce A McClane
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Phenotypic characterization of enterotoxigenic Clostridium perfringens isolates from non-foodborne human gastrointestinal diseases.

Authors:  R E Collie; J F Kokai-Kun; B A McClane
Journal:  Anaerobe       Date:  1998-04       Impact factor: 3.331

5.  Effect of carbohydrates and control of culture pH on beta toxin production by Clostridium perfringens type C.

Authors:  J Sakurai; C L Duncan
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

Review 6.  Fatal enteritis necroticans (pigbel) in a diabetic adult.

Authors:  Lizhen Gui; Charu Subramony; Jonathan Fratkin; Michael D Hughson
Journal:  Mod Pathol       Date:  2002-01       Impact factor: 7.842

7.  Regulated expression of Clostridium perfringens enterotoxin in naturally cpe-negative type A, B, and C isolates of C. perfringens.

Authors:  J R Czeczulin; R E Collie; B A McClane
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

8.  Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene.

Authors:  M M Awad; D M Ellemor; R L Boyd; J J Emmins; J I Rood
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Clostridium perfringens type C causing necrotising enteritis.

Authors:  W P Severin; A A de la Fuente; M F Stringer
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

10.  Impact of active immunisation against enteritis necroticans in Papua New Guinea.

Authors:  G W Lawrence; D Lehmann; G Anian; C A Coakley; G Saleu; M J Barker; M W Davis
Journal:  Lancet       Date:  1990-11-10       Impact factor: 79.321

View more
  51 in total

Review 1.  Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections.

Authors:  F A Uzal; B A McClane
Journal:  Vet Microbiol       Date:  2011-02-26       Impact factor: 3.293

2.  Identification and characterization of Clostridium perfringens beta toxin variants with differing trypsin sensitivity and in vitro cytotoxicity activity.

Authors:  James R Theoret; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 3.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

4.  Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid.

Authors:  Kazuaki Miyamoto; Jihong Li; Sameera Sayeed; Shigeru Akimoto; Bruce A McClane
Journal:  J Bacteriol       Date:  2008-09-05       Impact factor: 3.490

Review 5.  Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease.

Authors:  Francisco A Uzal; John C Freedman; Archana Shrestha; James R Theoret; Jorge Garcia; Milena M Awad; Vicki Adams; Robert J Moore; Julian I Rood; Bruce A McClane
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

6.  Fecal pollution in coastal marine sediments from a semi-enclosed deep embayment subjected to anthropogenic activities: an issue to be considered in environmental quality management frameworks development.

Authors:  D González-Fernández; M C Garrido-Pérez; E Nebot-Sanz; D Sales-Márquez
Journal:  Ecohealth       Date:  2011-01-12       Impact factor: 3.184

7.  Lethal effects of Clostridium perfringens epsilon toxin are potentiated by alpha and perfringolysin-O toxins in a mouse model.

Authors:  Mariano E Fernandez-Miyakawa; B Helen Jost; Stephen J Billington; Francisco A Uzal
Journal:  Vet Microbiol       Date:  2007-10-02       Impact factor: 3.293

8.  Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops.

Authors:  Menglin Ma; Abhijit Gurjar; James R Theoret; Jorge P Garcia; Juliann Beingesser; John C Freedman; Derek J Fisher; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

9.  Use of an EZ-Tn5-based random mutagenesis system to identify a novel toxin regulatory locus in Clostridium perfringens strain 13.

Authors:  Jorge E Vidal; Jianming Chen; Jihong Li; Bruce A McClane
Journal:  PLoS One       Date:  2009-07-14       Impact factor: 3.240

10.  Further characterization of Clostridium perfringens small acid soluble protein-4 (Ssp4) properties and expression.

Authors:  Jihong Li; Daniel Paredes-Sabja; Mahfuzur R Sarker; Bruce A McClane
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.